Warrants (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Warrants And Rights Note Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of Warrant Activity |
The Company issued several notes in prior periods and converted them resulting in the issuance of Series B Convertible Preferred Stock warrants. The following table summarizes information about the Company’s warrants at September 30, 2020 and September 30, 2019, respectively:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of Information Assuming Warrants are Exercised and Exchanged for Common Shares |
As discussed in Note 9 Stockholders’ Equity, the warrants may be exchanged for shares of common stock at a ratio of one share of Series B Preferred Stock into five common shares. The following table provides information assuming the warrants are exercised and exchanged for common shares:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of Warrants Outstanding and Exercisable |
The exercise price for the Series B convertible preferred stock warrants outstanding and exercisable at September 30, 2020 is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||